πŸ‡ΊπŸ‡Έ FDA
Patent

US 11433137

Compounds for treating cancer

granted A61KA61K38/08A61K47/64

Quick answer

US patent 11433137 (Compounds for treating cancer) held by BicycleRD Limited expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleRD Limited
Grant date
Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K38/08, A61K47/64, A61K47/65, A61P